Phio Pharmaceuticals Corp. (PHIO)

SEC filing

Phio Pharmaceuticals Corp.

PHIO · CIK 1533040

4 · Sep 30, 2026 · Director Plott Ronald Todd bought 10K Common Stock, $.0001 par value at $1.04/unit ($10,350)

Director Plott Ronald Todd bought 10K Common Stock, $.0001 par value at $1.04/unit ($10,350)

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Graphics and non-inline formats (not embedded below).